Fate Therapeutics Inc(FATE)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

FATE Fate Therapeutics Inc

已收盘 05-17 16:00:00 EDT

3.90

-0.24

-5.80%

盘后3.88

-0.02-0.51%

17:58 EDT

最高4.18	最低3.87	成交量134.20万
今开4.18	昨收4.14	日振幅7.49%
总市值4.44亿	流通市值3.61亿	总股本1.14亿
成交额531.59万	换手率1.45%	流通股本9,252万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"FATE","market":"US","secType":"STK","nameCN":"Fate Therapeutics Inc","latestPrice":3.9,"timestamp":1715976000000,"preClose":4.14,"halted":0,"volume":1342024,"hourTrading":{"tag":"盘后","latestPrice":3.88,"preClose":3.9,"latestTime":"17:58 EDT","volume":31065,"amount":121152.72,"timestamp":1715983090785},"delay":0,"floatShares":92516887,"shares":113831969,"eps":-1.918686,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.24,"latestTime":"05-17 16:00:00 EDT","open":4.18,"high":4.18,"low":3.87,"amount":5315905.7602592,"amplitude":0.074879,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.918686,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1716192000000},"adr":0,"listingDate":1380600000000,"adjPreClose":4.14,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":3.88,"preClose":3.9,"latestTime":"17:58 EDT","volume":31065,"amount":121152.72,"timestamp":1715983090785},"volumeRatio":0.440175},"requestUrl":"/m/hq/s/FATE/wiki","defaultTab":"wiki","newsList":[{"id":"2436946699","title":"Fate Therapeutics, Inc.2024财年第一财季实现净利润-48.00百万美元，同比减少154.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2436946699","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2436946699?lang=zh_cn&edition=full","pubTime":"2024-05-18 00:26","pubTimestamp":1715963214,"startTime":"0","endTime":"0","summary":"3月31日，Fate Therapeutics, Inc.公布财报，公告显示公司2024财年第一财季净利润为-48.00百万美元，同比减少154.24%；其中营业收入为1.93百万美元，同比减少96.73%，每股基本收益为-0.47美元。机构评级：截至2024年3月31日，当前有16家机构对Fate Therapeutics, Inc.目标价做出预测，其中目标均价为6.81美元，其中最低目标价为4.00美元，最高目标价为12.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405180026578b131de0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405180026578b131de0&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2435519403","title":"Fate Therapeutics, Inc.盘中异动 早盘股价大涨5.06%报4.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2435519403","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2435519403?lang=zh_cn&edition=full","pubTime":"2024-05-14 21:32","pubTimestamp":1715693570,"startTime":"0","endTime":"0","summary":"北京时间2024年05月14日21时32分，Fate Therapeutics, Inc.股票出现波动，股价急速上涨5.06%。Fate Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.14%。Fate Therapeutics, Inc.公司简介：Fate Therapeutics Inc是一家总部位于美国的临床阶段生物制药公司。该信息摘要如下：加拿大投资银行集团：维持Fate Therapeutics评级，由买入调整至买入评级, 目标价由11.00美元调整至9.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405142132507a59d890&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405142132507a59d890&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2435782693","title":"Fate Therapeutics, Inc.盘中异动 早盘大幅上涨5.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2435782693","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2435782693?lang=zh_cn&edition=full","pubTime":"2024-05-13 21:31","pubTimestamp":1715607078,"startTime":"0","endTime":"0","summary":"北京时间2024年05月13日21时31分，Fate Therapeutics, Inc.股票出现异动，股价大幅拉升5.39%。Fate Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.99%。Fate Therapeutics, Inc.公司简介：Fate Therapeutics Inc是一家总部位于美国的临床阶段生物制药公司。该信息摘要如下：加拿大投资银行集团：维持Fate Therapeutics评级，由买入调整至买入评级, 目标价由11.00美元调整至9.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240513213118861eccba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240513213118861eccba&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2434514118","title":"Fate Therapeutics, Inc.盘中异动 大幅跳水5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2434514118","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2434514118?lang=zh_cn&edition=full","pubTime":"2024-05-10 21:35","pubTimestamp":1715348143,"startTime":"0","endTime":"0","summary":"北京时间2024年05月10日21时35分，Fate Therapeutics, Inc.股票出现异动，股价急速下挫5.13%。Fate Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.26%。其相关个股中，诺瓦瓦克斯医药、Clene Inc C/Wts 30/12/2025 、Artelo Biosciences Inc C/Wts 20/06/2024 涨幅较大，诺瓦瓦克斯医药、Allarity Therapeutics, Inc.、Clearmind Medicine Inc.较为活跃，换手率分别为36.75%、19.68%、7.20%，振幅较大的相关个股有Celularity Inc C/Wts 16/07/2026 、诺瓦瓦克斯医药、内克塔治疗，振幅分别为31.88%、21.03%、15.00%。Fate Therapeutics, Inc.公司简介：Fate Therapeutics Inc是一家总部位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405102135437a5940d5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405102135437a5940d5&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433420476","title":"Wedbush：重申Fate Therapeutics(FATE.US)评级，由中性调整至中性评级, 目标价7.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2433420476","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2433420476?lang=zh_cn&edition=full","pubTime":"2024-05-06 20:37","pubTimestamp":1714999022,"startTime":"0","endTime":"0","summary":"Wedbush：重申Fate Therapeutics(FATE.US)评级，由中性调整至中性评级, 目标价7.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405062037088ae13fe9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405062037088ae13fe9&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432838680","title":"Fate Therapeutics, Inc.盘中异动 下午盘股价大涨5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432838680","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432838680?lang=zh_cn&edition=full","pubTime":"2024-05-02 02:07","pubTimestamp":1714586846,"startTime":"0","endTime":"0","summary":"北京时间2024年05月02日02时07分，Fate Therapeutics, Inc.股票出现异动，股价大幅拉升5.06%。Fate Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.18%。其相关个股中，Cytomx Therapeutics, Inc.、Cyclacel Pharmaceuticals, Inc.、Aptevo Therapeutics Inc.涨幅较大，Palisade Bio, Inc.、Cyclacel Pharmaceuticals, Inc.、Cytomx Therapeutics, Inc.较为活跃，换手率分别为1401.56%、843.96%、249.96%，振幅较大的相关个股有Cytomx Therapeutics, Inc.、Cyclacel Pharmaceuticals, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ，振幅分别为188.34%、84.43%、77.43%。Fate Therapeutics, Inc.公司简介：Fate Therapeutics Inc是一家总部位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240502020726861ea909&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240502020726861ea909&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430728661","title":"Fate Therapeutics, Inc.盘中异动 早盘快速下挫6.74%报4.01美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430728661","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430728661?lang=zh_cn&edition=full","pubTime":"2024-04-25 21:32","pubTimestamp":1714051952,"startTime":"0","endTime":"0","summary":"北京时间2024年04月25日21时32分，Fate Therapeutics, Inc.股票出现波动，股价大幅跳水6.74%。Fate Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.50%。其相关个股中，Processa Pharmaceuticals, Inc.、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Zura Bio Limited C/Wts 涨幅较大，Processa Pharmaceuticals, Inc.、Cyclacel Pharmaceuticals, Inc.、Cidara Therapeutics, Inc.较为活跃，换手率分别为529.12%、181.04%、5.85%，振幅较大的相关个股有Cassava Sciences Inc C/Wts 15/11/2024、Processa Pharmaceuticals, Inc.、Lyell Immunopharma, Inc.，振幅分别为18.13%、14.20%、12.14%。Fate Therapeutics, Inc.公司简介：Fate Therapeutics Inc是一家总部位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240425213232861e9064&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240425213232861e9064&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429788148","title":"Fate Therapeutics, Inc.盘中异动 急速下挫5.13%报4.54美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429788148","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429788148?lang=zh_cn&edition=full","pubTime":"2024-04-24 01:31","pubTimestamp":1713893489,"startTime":"0","endTime":"0","summary":"北京时间2024年04月24日01时31分，Fate Therapeutics, Inc.股票出现波动，股价大幅下挫5.13%。Fate Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.50%。其相关个股中，Revolution Medicines Inc C/Wts 17/12/2026 、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Palisade Bio, Inc.涨幅较大，Palisade Bio, Inc.、Silo Pharma, Inc.、Abvc Biopharma, Inc.较为活跃，换手率分别为2618.20%、180.88%、51.61%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Revolution Medicines Inc C/Wts 17/12/2026 、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为80.08%、61.52%、56.09%。Fate Therapeutics, Inc.公司简介：Fate Therapeutics Inc是一家总部位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404240131297922b745&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404240131297922b745&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428460465","title":"Fate Therapeutics, Inc.盘中异动 下午盘股价大跌5.03%报5.01美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428460465","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428460465?lang=zh_cn&edition=full","pubTime":"2024-04-19 03:17","pubTimestamp":1713467834,"startTime":"0","endTime":"0","summary":"北京时间2024年04月19日03时17分，Fate Therapeutics, Inc.股票出现异动，股价大幅跳水5.03%。截至发稿，该股报5.01美元/股，成交量117.776万股，换手率1.04%，振幅6.36%。Fate Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.62%。Fate Therapeutics, Inc.公司简介：Fate Therapeutics Inc是一家总部位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404190317157a53d1d7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404190317157a53d1d7&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426729483","title":"Fate Therapeutics, Inc.盘中异动 股价大跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426729483","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426729483?lang=zh_cn&edition=full","pubTime":"2024-04-12 03:01","pubTimestamp":1712862087,"startTime":"0","endTime":"0","summary":"北京时间2024年04月12日03时01分，Fate Therapeutics, Inc.股票出现异动，股价大幅下跌5.02%。Fate Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.05%。Fate Therapeutics, Inc.公司简介：Fate Therapeutics Inc是一家总部位于美国的临床阶段生物制药公司。消息层面，截至03时01分，《Needham：重申Fate Therapeutics持有评级。》资讯为影响Fate Therapeutics, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240412030128861e508b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240412030128861e508b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426494207","title":"Fate Therapeutics, Inc.盘中异动 大幅下挫6.21%报6.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426494207","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426494207?lang=zh_cn&edition=full","pubTime":"2024-04-10 21:32","pubTimestamp":1712755963,"startTime":"0","endTime":"0","summary":"北京时间2024年04月10日21时32分，Fate Therapeutics, Inc.股票出现波动，股价快速下跌6.21%。Fate Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.25%。其相关个股中，Adial Pharmaceuticals, Inc、Tc Biopharm  Plc C/Wts 10/02/2028 、Jaguar Health, Inc.涨幅较大，Adial Pharmaceuticals, Inc、Silo Pharma, Inc.、Abvc Biopharma, Inc.较为活跃，换手率分别为941.31%、62.91%、23.01%，振幅较大的相关个股有Adial Pharmaceuticals, Inc、X4制药、Foghorn Therapeutics Inc.，振幅分别为29.20%、13.39%、10.46%。Fate Therapeutics, Inc.公司简介：Fate Therapeutics Inc是一家总部位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240410213244876167de&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240410213244876167de&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422510058","title":"Fate Therapeutics, Inc.盘中异动 早盘股价大涨5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422510058","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422510058?lang=zh_cn&edition=full","pubTime":"2024-03-25 21:46","pubTimestamp":1711374383,"startTime":"0","endTime":"0","summary":"北京时间2024年03月25日21时46分，Fate Therapeutics, Inc.股票出现波动，股价快速拉升5.14%。Fate Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.15%。其相关个股中，Landos Biopharma, Inc.、Altamira Therapeutics Ltd.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 涨幅较大，Altamira Therapeutics Ltd.、Salarius Pharmaceuticals, Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为1723.73%、55.15%、31.62%，振幅较大的相关个股有Altamira Therapeutics Ltd.、Xtl生物制药、Sagimet Biosciences Inc. - Series A，振幅分别为36.42%、20.61%、15.86%。Fate Therapeutics, Inc.公司简介：Fate Therapeutics Inc是一家总部位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403252146247a4ee896&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403252146247a4ee896&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.fatetherapeutics.com","stockEarnings":[{"period":"1week","weight":0.0615},{"period":"1month","weight":-0.2305},{"period":"3month","weight":-0.4524},{"period":"6month","weight":0.7037},{"period":"1year","weight":-0.1769},{"period":"ytd","weight":0.107}],"compareEarnings":[{"period":"1week","weight":0.0164},{"period":"1month","weight":0.05},{"period":"3month","weight":0.0584},{"period":"6month","weight":0.1728},{"period":"1year","weight":0.2732},{"period":"ytd","weight":0.1123}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Fate Therapeutics, Inc.于2007年4月27日在特拉华州合并，是一家临床分期生物制药公司，致力于成体干细胞治疗调节器的探索与开发，治疗罕见疾病，包括一些恶性血液病、溶酶体贮积症和肌肉营养不良。Fate使用的一些新方法采用已有的治疗模式，包括小分子和治疗性蛋白，并瞄准良好的生物机制，以增强成体干细胞的疗效。","yearOnYearQuotes":[{"month":1,"riseRate":0.545455,"avgChangeRate":0.058546},{"month":2,"riseRate":0.636364,"avgChangeRate":0.08272},{"month":3,"riseRate":0.545455,"avgChangeRate":0.019657},{"month":4,"riseRate":0.545455,"avgChangeRate":-0.055265},{"month":5,"riseRate":0.545455,"avgChangeRate":-0.006315},{"month":6,"riseRate":0.6,"avgChangeRate":0.022155},{"month":7,"riseRate":0.4,"avgChangeRate":-0.000476},{"month":8,"riseRate":0.4,"avgChangeRate":0.007076},{"month":9,"riseRate":0.4,"avgChangeRate":-0.015658},{"month":10,"riseRate":0.2,"avgChangeRate":-0.084781},{"month":11,"riseRate":0.545455,"avgChangeRate":0.090798},{"month":12,"riseRate":0.636364,"avgChangeRate":0.109378}],"exchange":"NASDAQ","name":"Fate Therapeutics Inc","nameEN":"Fate Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Fate Therapeutics Inc(FATE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Fate Therapeutics Inc(FATE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Fate Therapeutics Inc,FATE,Fate Therapeutics Inc股票,Fate Therapeutics Inc股票老虎,Fate Therapeutics Inc股票老虎国际,Fate Therapeutics Inc行情,Fate Therapeutics Inc股票行情,Fate Therapeutics Inc股价,Fate Therapeutics Inc股市,Fate Therapeutics Inc股票价格,Fate Therapeutics Inc股票交易,Fate Therapeutics Inc股票购买,Fate Therapeutics Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Fate Therapeutics Inc(FATE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Fate Therapeutics Inc(FATE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}